Affiliation:
1. MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK
2. Department of Infectious Disease, Imperial College London, London, UK
Abstract
We use viral kinetic models fitted to viral load data from
in vitro
studies to explain why the SARS-CoV-2 Omicron variant replicates faster than the Delta variant in nasal cells, but slower than Delta in lung cells, which could explain Omicron's higher transmission potential and lower severity. We find that in both nasal and lung cells, viral infectivity is higher for Omicron but the virus production rate is higher for Delta, with an estimated approximately 200-fold increase in infectivity and 100-fold decrease in virus production when comparing Omicron with Delta in nasal cells. However, the differences are unequal between cell types, and ultimately lead to the basic reproduction number and growth rate being higher for Omicron in nasal cells, and higher for Delta in lung cells. In nasal cells, Omicron alone can enter via a TMPRSS2-independent pathway, but it is primarily increased efficiency of TMPRSS2-dependent entry which accounts for Omicron's increased activity. This work paves the way for using within-host mathematical models to understand the transmission potential and severity of future variants.
Funder
Imperial College Research Fellowship
Medical Research Council/UK Research and Innovation
MRC Centre for Global Infectious Disease Analysis
Wellcome Trust and Royal Society
Subject
Biomedical Engineering,Biochemistry,Biomaterials,Bioengineering,Biophysics,Biotechnology
Reference63 articles.
1. WHO. 2021 Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern . WHO. See https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.
2. GISAID. 2022 GISAID-hCov19 Variants . GISAID. See https://gisaid.org/hcov19-variants/.
3. WHO. 2021 Tracking SARS-CoV-2 variants. WHO. See https://www.who.int/activities/tracking-SARS-CoV-2-variants.
4. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
5. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献